Christof Bull

Assistant General Patent Counsel

UCB

Vivek Lal

CEO

Alveolus Bio

Robert JM Brummer MD PhD

Pro-Vice-Chancellor, Food & Health

Orebro University

Rikke Nielson

CEO

BEO Therapeutics

Fabio Grassi

Chairman

MVBiotherapeutics

Eric Van der Helm

VP Scientific Affairs, Bioinformatics & Automation

SNIPR Bio

Dev Verma

Medical Officer, Center for Drug Evaluation and Research

FDA

Dev graduated from Columbia University in 2007 with an undergraduate degree in biochemistry (summa cum laude), Harvard Medical School in 2011, and completed his plastic and reconstructive surgery residency training at Georgetown University Hospital in 2018. For several years he worked as a private practice plastic surgeon, with a focus on complex wound care. In 2020 he transitioned his career to pharmaceutical drug regulation and began working as a medical officer clinical reviewer in the Division of Dermatology and Dentistry in the Center for Drug Evaluation and Research (CDER) at FDA. He is an active participant in the Wound Care Collaborative Community (WCCC) and is optimistic that continued FDA engagement with external stakeholders working in the wound care space will ultimately lead to safe, effective, and innovative products for patients.

Tamara Chisholm

Senior Legal Director, Global Compliance

GILEAD SCIENCES (UK)